A Long-term Study Of Policosanol In The Treatment Of Intermittent Claudication

Effect Decrease
Trial Design Double blind
Trial Length n/a
Number of Subjects 56
Sex n/a
Notes for this study:
Policosanol, at 20mg daily for 2 years, showed time-dependent increases in functional capacity in persons suffering from intermittent claudation

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.